Advertisement

Topics

Encore, A Quintiles Company Company Profile

22:32 EST 13th December 2018 | BioPortfolio

Encore, A Quintiles Company, is an award-winning leader in health-information technology services and solutions. Founded in 2009 and led by Encore CEO Dana Sellers and President Tom Niehaus, the company provides consulting services and solutions that assist its expanding client base with a wide range of HIT strategy, advisory, implementation, process-redesign, and optimization initiatives. Encore focuses on capturing the right data at the right time, establishing analytical capabilities that meet the evolving information and reporting needs of healthcare providers to document and improve clinical and operational performance. To learn more about Encore, please visit www.encorehealthresources.com.


News Articles [62 Associated News Articles listed on BioPortfolio]

Quintiles And Variagenics Establish Pharmacogenomic Partnership

In one of the last significant pieces of business in 1998, Quintiles Transnational Corp. (Research Triangle Park, NC) and Variagenics, Inc. (Cambridge MA) formed a strategic alliance for commercializi...

Capsa's New Vintage Encore Medication Carts For Senior Care Facilities

PORTLAND, Ore. (PRWEB) October 03, 2018 Capsa Healthcare announces the release of the new Vintage Encore medication cart for senio...

REVA Medical announces first implant of Fantom Encore in post market trial

The implant procedure was performed by Dr. Matthias Lutz at the Universitätsklinikum Schleswig-Holstein in Kiel, Germany. Fantom Encore is a third-generation coronary BRS with a market-leading thin s...

REVA Announces First Implant of the Fantom Encore Bioresorbable Scaffold in Italy

REVA Medical (ASX:RVA) a leader in bioresorbable polymer technologies for vascular applications, announced the first implant of its recently launched Fantom Encore bioresorbable scaffold (BRS) in Ita...

Encore Medical Education stellt Best of SABCS® News vom San Antonio Breast Cancer Symposium ...

SAN ANTONIO, December 2, 2018 /PRNewswire/ -- Encore Medical Education wird die Best of SABCS® News bereitstellen, ein Nachrichtenformat, das die wichtigsten Ergebnisse des vom Read more...

Encore Medical Education publicará las Best of SABCS® News del Simposio sobre Cáncer de Mama ...

SAN ANTONIO, 2 de diciembre de 2018 /PRNewswire/ -- Encore Medical Education publicará las Best of SABCS® News destacando las conclusiones clave presentadas en la Read more...

Encore Medical Education publicará seu Best of SABCS® News do Simpósio sobre Câncer de Mama ...

SAN ANTONIO, 3 de dezembro de 2018 /PRNewswire/ -- A Encore Medical Education publicará seu Best of SABCS® News destacando as principais conclusões do 41o Read more...

Conatus Announces Results from ENCORE-PH Phase 2b Clinical Trial in NASH Cirrhosis

Conatus Pharmaceuticals (Nasdaq:CNAT) today announced top-line results from the company’s Phase 2b ENCORE-PH clinical trial showing clinically meaningful treatment effects in compensated NASH cirrho...

PubMed Articles [35 Associated PubMed Articles listed on BioPortfolio]

Characteristics of Occupational Injuries in a Pharmaceutical Company in Iran.

To prioritize occupational hazards in a Pharmaceutical Company in Iran using the analytical hierarchy process (AHP).

Inequality in total fertility rates and the proximate determinants of fertility in 21 sub-Saharan African countries.

In this paper, we examine the inequality in the dynamics of the total fertility rate within 21 sub-Saharan African countries by wealth quintiles. We also examine the associated inequality within each ...

Encore adulthood: Boomers on the edge of risk, renewal, and purpose.

A Man (or a Woman) is Known by the Company He/She Keeps.

High Serum Serotonin Predicts Increased Risk for Hip Fracture and Nonvertebral Osteoporotic Fractures: The MrOS Sweden Study.

Because several studies have implicated serotonin as a regulator of bone mass, we here explore its potential association on fracture risk and falls, as on bone mineral density (BMD) and muscle strengt...

Clinical Trials [99 Associated Clinical Trials listed on BioPortfolio]

3DKnee™ System vs. the MJS Knee System

The purpose of this study is to compare the survivorship and efficacy of the Encore 3DKnee™ system with that of the Encore MJS™ Knee System in a group of 600 patients for whom data col...

Retrospective Encore Reverse Shoulder Prosthesis Study

The purpose of this study is to evaluate the survivorship and efficacy of the Encore Reverse Shoulder Prosthesis in a group of no more than 50 subjects for whom data collection has already...

Efficacy of the CLP® Hip - Retrospective

The purpose of this study is to evaluate the survivorship and efficacy of the Encore CLP® Hip stem in a group of no more than 200 patients from whom data has already been collected.

Retrospective Study of the Linear™ Hip

The purpose of this study is to evaluate the use and efficacy of the Encore Linear™ Hip System in a group of 200 patients for whom data has already been collected.

Improving Negative Symptoms & Community Engagement in Veterans With Schizophrenia

The goal of this project is to evaluate an innovative psychosocial intervention package that will incorporate evidence-based treatment strategies to target the affective-motivational defic...

Companies [1480 Associated Companies listed on BioPortfolio]

Encore, A Quintiles Company

Encore, A Quintiles Company, is an award-winning leader in health-information technology services and solutions. Founded in 2009 and led by Encore CEO Dana Sellers and President T...

Quintiles

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of mo...

Quintiles Transnational Holdings Inc.

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more ...

Quintiles and IMS Health

Quintiles (NYSE:Q) helps biopharma and other healthcare companies improve their probability of success by connecting insights from our deep scientific, therapeutic and analytics e...

Encore Health Resources

Encore Health Resources, founded by healthcare veterans Ivo Nelson and Dana Sellers, provides information technology consulting services to the provider segment of the healthcare ...

More Information about "Encore, A Quintiles Company" on BioPortfolio

We have published hundreds of Encore, A Quintiles Company news stories on BioPortfolio along with dozens of Encore, A Quintiles Company Clinical Trials and PubMed Articles about Encore, A Quintiles Company for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Encore, A Quintiles Company Companies in our database. You can also find out about relevant Encore, A Quintiles Company Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record